Movva N , Reichert H , Hooda N , Bylsma LC , Mitchell M , Cohen SS. 2023. Dietary eating patterns, dairy consumption, and anxiety: A systematic literature review. PLoS One 18(12):e0295975. doi: 10.1371/journal.pone.0295975 . PMID: 38153944.
View Abstract
Publication: Manuscripts
/ Topics: nutrition , Systematic Review
Garrison K, Zhang W, Jensen I , Shah A, Brown S, Stephenson B, Yim C. Cost-utility analysis of roflumilast cream for plaque psoriasis, including intertriginous, from the Canadian societal perspective. Abstract EE303 , ISPOR EU 2023.
View Abstract
Publication: Abstracts and Presentations
/ Topics: Health Economics and Outcomes Research (HEOR)
Gutierrez M, Wild S, Compton A, Paine E, Jensen I , Shah A. Cost consequences of using clevidipine in neurological emergencies from the perspective of a US hospital. Abstract EE579 , ISPOR EU 2023.
View Abstract
Publication: Abstracts and Presentations
/ Topics: Health Economics and Outcomes Research (HEOR)
Gutierrez M, Wild S, Compton A, Paine E, Jensen I , Shah A. Cost consequences of using clevidipine in cardiac surgery from the perspective of a US hospital. Abstract EE734 , ISPOR EU 2023.
View Abstract
Publication: Abstracts and Presentations
/ Topics: Health Economics and Outcomes Research (HEOR)
Gutierrez M, Wild S, Compton A, Paine E, Jensen I , Shah A. Cost consequences of using clevidipine in acute hypertension from the perspective of a US hospital. Abstract EE125 , ISPOR EU 2023.
View Abstract
Publication: Abstracts and Presentations
/ Topics: Health Economics and Outcomes Research (HEOR)
Bean K, Miller B, Jensen I , Howle K, Wilds A, Walz M, et al. The societal costs of metachromatic leukodystrophy (MLD) in the United States. Abstract EE547 , ISPOR EU 2023.
View Abstract
Publication: Abstracts and Presentations
/ Topics: Health Economics and Outcomes Research (HEOR) , Metachromatic leukodystrophy (MLD)
Miller B, Russel-Szymczyk M, Jensen I , Shah A, Alexopoulos T, Herbert A, et al. Cost-consequence of cladribine tablets for the treatment of highly-active relapsing-remitting multiple sclerosis (RRMS) in the UK. Abstract EE658 , ISPOR EU 2023.
View Abstract
Publication: Abstracts and Presentations
/ Topics: Health Economics and Outcomes Research (HEOR)
Yoshino T, Hooda N , Younan D, Shitara K, Heinemann V,…, Suh M , Reichert H , et al. A meta-analysis of efficacy and safety from head-to-head first-line (1L) trials of epidermal growth factor receptor inhibitors (EGFRIs) versus bevacizumab in combination with chemotherapy (CT) doublets in patients with RAS wild-type (WT) metastatic colorectal cancer (mCRC) by sidedness. Abstract 127P, European Society for Medical Oncology (ESMO) Asia Congress. Ann Oncol 34(Sup 4):S1519; doi: 10.1016/j.annonc.2023.10.262 . Singapore, December 2023.
View Abstract
Publication: Abstracts and Presentations
/ Topics: Cancer , Epidemiology
Davies S, Boller E, Beaubrun A, Miller C, Jensen I . A cost-consequence analysis of the Xpert Xpress CoV-2/Flu/RSV Plus for the diagnosis of viral respiratory infections from a US health plan perspective. Abstract ID309, AMP 2023 Annual Meeting & Expo, Salt Lake City, UT, November 2023.
View Abstract